Main Article Content

Authors





Introduction: The development achieved in regenerative medicine has allowed the treatment of incurable diseases or those with a reduced response to current therapies, as well as cases with decreased consumption of medicines. In Cuba, angiology, orthopedic, and traumatology specialists use this therapy the most. In this paper, we have presented the statistical analysis using the statgraphics® Centurion XVI for controlled variables in two osteoarthritis-knee treatments, one using mononuclear stem cells obtained from the peripheral blood and the other with a conventional therapy so as to demonstrate the superiority of the new treatment regime. Case report: A total of 100 adult patients treated in the Orthopedic Department at the Hematology and Immunology Institute for osteoarthritis-knee pains were studied. Group A (control) received the conventional treatment with triamcinolone acetate infiltration in the affected knee. Group B received the percutaneous implantation of the hematopoietic adult mononuclear cell concentrate. Conclusion: The analysis of each of the variables was performed to verify that most of the collected data did not comply with a normal distribution; hence, the following tests were performed taking the median of each sample as a reference. Comparisons were made between the evaluation of pain to the activity, as well as the consumption of drugs from each of the treatment groups. The best response of the patients was indicated for treatments with stem cells and a decrease in the consumption of drugs.





Hermida Vitar, D. P., Zumalacárregui de Cárdenas, L. ., & García Suárez, J. (2021). Using Mononuclear Stem Cells for Osteoarthritis-Knee Treatments: A Case Study in Cuba. Revista Ciencias De La Salud, 19(2). https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.10284

Prósper F, Gavira JJ, Herreros J, Rábago G, Luquin R, Moreno J, Robles JE, Redondo P. Trasplante celular y terapia regenerativa con células madre. An Sist Sanit Navar. 2006;29(supl. 2):219-34.

Directiva 2004/23/Ce del Parlamento Europeo y del Consejo de 31 de marzo de 2004 relativa al establecimiento de normas de calidad y de seguridad para la donación, la obtención, la evaluación, el procesamiento, la preservación, el almacenamiento y la distribución de células y tejidos humanos.

Food and Drug Administration. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing, 21 cfr Parts 207, 807, and 1271 [internet]. 2001 ene 19. Disponible en: https://www.federalregister.gov/documents/2001/01/19/01-1126/humancells-tissues-and-cellular-and-tissue-based-products-establishment-registra- tion-and-listing

Estopá-Dueso J. Aspectos científicos, técnicos y éticos de la terapia celular y medicina regenerativa [tesis doctorado]. León: Universidad de León; 2013.

Hernández-Ramírez P, Forrellat Barrios M. Ventajas de la terapia celular con células mononucleares derivadas de la médula ósea, aplicadas en su conjunto. Rev Cubana Hematol Inmunol Hemoter. 2013;29(4):407-12.

Picón-Ruiz M. Aislamiento y caracterización de células madre/progenitoras y tumorales humanas: potencial terapéutico e implicaciones en carcinogénesis [tesis de doctorado]. Granada: Universidad de Granada; 2012.

Hernández-Ramírez P. Medicina regenerativa y células madre: resultados con el uso de componentes de la sangre. Documento procedente de la Jornada Científica de Medicina Regenerativa; 2015; La Habana, Cuba.

Roque L, Alfonso Y, Plaín C. Aplicaciones de las células madre en la angiología cubana. Revista Universidad Médica Pinareña. 2018;14(3):276-88.

Feito T, Perurena C, Aparicio JL, Bustillo MJ, García F. Implante de células madre hematopoyéticas en pacientes con isquemia crónica de los miembros inferiores. Rev Cuba Angiol Cir Vasc. 2015;16(1):64-75.

Camacho J, Camacho L, Gómez N, Camacho A, López K, García L. Células madre: gene- ralidades (parte ii). Mediciego. 2017;23(3):35-44.

Statgraphics® Centurion xvi. StatPoint Technologies, Inc. 2009. EE. UU.

Cruz-Sánchez P, Gámez-Pérez A, Rodríguez-Orta C, González Y, López E, Pérez D, et al. Impacto del tratamiento con células madre adultas en la osteoartrosis de la rodilla. Rev Cubana Hematol Inmunol Hemoter. 2013;29(3):272-83.

Lugo A, Arce M, Hernández V, Díaz A, Díaz M. Medicina regenerativa en el tratamiento de la osteoartrosis de rodilla: experiencias en Villa Clara. Medicent Electrón. 2015;19(3):171-3.

Lamo-Espinosa J, Mora G, Blanco J, Granero F, Núñez-Córdoba J, Sánchez-Echenique C, et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase i/ii). J. Transl Med. 2016;14:246. https://doi.org/10.1186/s12967-016-0998-2

Downloads

Download data is not yet available.

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.